Astellas at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
Astellas exhibits at Booth 3512 at ASH 2026 in New Orleans. Astellas supports a symposium on current approaches to managing acute myeloid leukemia. It is built as a second-opinion review of patient cases.
| Organization | ASH 2026 Attendance |
|---|---|
Astellas Tokyo, Japan | |
Global pharmaceutical company based in Tokyo developing medicines for unmet medical needs, including therapies for acute myeloid leukemia. | Booth Exhibiting at Booth 3512 Sat, Dec 1211:00am–5:00pmSun, Dec 1310:00am–5:00pmMon, Dec 1410:00am–2:00pm Symposium Fri Dec 11 7:00am–10:00am Current Management Paradigms in Acute Myeloid Leukemia – A Second Opinion Case Review Difficult acute myeloid leukemia cases where doctors sought second opinions, paired with reviews of recent data, current management, and ongoing trials. |
Find decision makers at Astellas
Tell us what you sell and we’ll find the people at Astellas most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction